BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10446876)

  • 21. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
    Yosipovitch G; Hoon TS; Leok GC
    Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of corticosteroid-induced osteoporosis.
    Drug Ther Bull; 2010 Sep; 48(9):98-101. PubMed ID: 20810708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: Osteoporosis and inflammatory bowel disease.
    Bernstein CN; Leslie WD
    Aliment Pharmacol Ther; 2004 May; 19(9):941-52. PubMed ID: 15113361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longterm effect of intermittent cyclical etidronate therapy on corticosteroid-induced osteoporosis in Japanese patients with connective tissue disease: 7-year followup.
    Sato S; Takada T; Katsuki Y; Kimura N; Kaneko Y; Suwa A; Hirakata M; Kuwana M
    J Rheumatol; 2008 Jan; 35(1):142-6. PubMed ID: 18050368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of corticosteroid-induced osteoporosis: results of a patient survey.
    Buckley LM; Marquez M; Feezor R; Ruffin DM; Benson LL
    Arthritis Rheum; 1999 Aug; 42(8):1736-9. PubMed ID: 10446875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium and vitamin D therapy in corticosteroid bone loss: what is the evidence.
    Sambrook PN
    J Rheumatol; 1996 Jun; 23(6):963-4. PubMed ID: 8782123
    [No Abstract]   [Full Text] [Related]  

  • 27. Calcium and vitamin D therapy in corticosteroid-induced bone loss: what is the evidence?
    Adachi JD; Ioannidis G
    Calcif Tissue Int; 1999 Oct; 65(4):332-6. PubMed ID: 10485987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies.
    de Nijs RN; Jacobs JW; Algra A; Lems WF; Bijlsma JW
    Osteoporos Int; 2004 Aug; 15(8):589-602. PubMed ID: 15138667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Corticosteroid-induced osteoporosis: a guide to optimum management.
    Cranney A; Adachi JD
    Treat Endocrinol; 2002; 1(5):271-9. PubMed ID: 15832482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Supplementation of vitamin D plus calcium is effective in corticosteroid-induced osteoporosis management.
    Bijlsma JW
    Clin Exp Rheumatol; 2000; 18(1):3-4. PubMed ID: 10777337
    [No Abstract]   [Full Text] [Related]  

  • 31. Corticosteroid-induced bone loss. Prevention and management.
    Picado C; Luengo M
    Drug Saf; 1996 Nov; 15(5):347-59. PubMed ID: 8941496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.
    Dequeker J; Westhovens R
    J Rheumatol; 1995 Jun; 22(6):1013-9. PubMed ID: 7674223
    [No Abstract]   [Full Text] [Related]  

  • 33. Calcium and vitamin D for corticosteroid-induced osteoporosis.
    Homik J; Suarez-Almazor ME; Shea B; Cranney A; Wells G; Tugwell P
    Cochrane Database Syst Rev; 2000; 1998(2):CD000952. PubMed ID: 10796394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment].
    Negri AL; Spivacow FR; Zanchetta JR
    Medicina (B Aires); 1992; 52(3):257-64. PubMed ID: 1342693
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of the efficiency of calcium and vitamin D in treating adults with corticosteroid-induced osteoporosis: A protocol for systematic review and meta-analysis.
    Pan SL; Li CC; Cui HW; Wang WX; Li CH
    Medicine (Baltimore); 2021 Oct; 100(39):e27197. PubMed ID: 34596117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention and treatment of corticosteroid-induced osteoporosis.
    Iwamoto J; Takeda T; Sato Y
    Yonsei Med J; 2005 Aug; 46(4):456-63. PubMed ID: 16127768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of corticosteroid-induced osteoporosis.
    Adachi JD; Olszynski WP; Hanley DA; Hodsman AB; Kendler DL; Siminoski KG; Brown J; Cowden EA; Goltzman D; Ioannidis G; Josse RG; Ste-Marie LG; Tenenhouse AM; Davison KS; Blocka KL; Pollock AP; Sibley J
    Semin Arthritis Rheum; 2000 Feb; 29(4):228-51. PubMed ID: 10707991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies on osteoporosis. IX. Effect of fluoride on steroid induced osteoporosis.
    Robin JC; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1982 Sep; 37(3):453-61. PubMed ID: 7178655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticosteroid-Induced osteoporosis: detection and management.
    Adachi JD; Papaioannou A
    Drug Saf; 2001; 24(8):607-24. PubMed ID: 11480493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of osteoporosis with fluoride.
    Riggs BL; Jowsey J
    Semin Drug Treat; 1972; 2(1):27-33. PubMed ID: 5048562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.